Diabetes is a disease that has a major economic impact on the US, with an estimated cost of $ 98 billion per year. It is of particularly high impact in the Native / Hispanic and African American communities. Diabetes is caused by an inability to produce or properly use insulin, resulting in hyperglycemia. The major health concern for diabetics is cardiovascular disease, particularly stroke, with diabetics having approximately 3 times higher probability of and mortality from stroke. One of the major factors in stroke progression and damage is brain edema formation. Brain edema during stroke has been linked to a large influx of ions into the brain, leading to water accumulation. Under normal conditions ion transport into the brain is tightly controlled by an interaction of the tight junctions and ion transporter of the blood central nervous system barriers (BCNSB). In diabetes, ion transport dysfunction has been reported in a number of organs. In animal models of stroke, infarct size and edema are increased in diabetics compared to non-diabetics. It is our hypothesis that during diabetes, both the tight junctions and ion transporters of the BCSNB are altered, resulting in a reduced ability to maintain ion homeostasis. During stroke this results in a larger influx of ions, leading to a more significant edema formation and thus more damage. We will test this hypothesis by investigating the effect of diabetes on BCNSB ion transporter and tight junction expression and function in control and diabetic animals. Our eventual goal is to gain a better understanding on the mechanisms involved in diabetic stroke damage, which will hopefully lead to better treatment paradigms

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK065003-01A1
Application #
6780335
Study Section
Special Emphasis Panel (ZRG1-CDIN (01))
Program Officer
Jones, Teresa L Z
Project Start
2004-04-01
Project End
2008-01-31
Budget Start
2004-04-01
Budget End
2005-01-31
Support Year
1
Fiscal Year
2004
Total Cost
$289,505
Indirect Cost
Name
University of Arizona
Department
Pharmacology
Type
Schools of Medicine
DUNS #
806345617
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Dom, Aaron M; Buckley, Adam W; Brown, Kathleen C et al. (2011) The ýý7-nicotinic acetylcholine receptor and MMP-2/-9 pathway mediate the proangiogenic effect of nicotine in human retinal endothelial cells. Invest Ophthalmol Vis Sci 52:4428-38
Egleton, Richard D; Brown, Kathleen C; Dasgupta, Piyali (2008) Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. Trends Pharmacol Sci 29:151-8
Hawkins, Brian T; Ocheltree, Scott M; Norwood, Kristi M et al. (2007) Decreased blood-brain barrier permeability to fluorescein in streptozotocin-treated rats. Neurosci Lett 411:1-5
Hom, Sharon; Fleegal, Melissa A; Egleton, Richard D et al. (2007) Comparative changes in the blood-brain barrier and cerebral infarction of SHR and WKY rats. Am J Physiol Regul Integr Comp Physiol 292:R1881-92
Hawkins, B T; Lundeen, T F; Norwood, K M et al. (2007) Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia 50:202-11
Hawkins, Brian T; Egleton, Richard D (2006) Fluorescence imaging of blood-brain barrier disruption. J Neurosci Methods 151:262-7
Egleton, Richard D; Davis, Thomas P (2005) Development of neuropeptide drugs that cross the blood-brain barrier. NeuroRx 2:44-53
Hawkins, Brian T; Abbruscato, Thomas J; Egleton, Richard D et al. (2004) Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution. Brain Res 1027:48-58